General Information of the Compound
| Compound ID |
CP0545009
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[6-[4-(3-chlorophenyl)piperazin-1-yl]hexyl]-2lambda6-thia-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene 2,2-dioxide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H33ClN4O2S
|
||||||||||||||||||
| Molecular Weight |
489.085
|
||||||||||||||||||
| Canonical SMILES |
Clc1cccc(c1)N1CCN(CCCCCCN2c3cccc4CCCN(c34)S2(=O)=O)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H33ClN4O2S/c26-22-10-6-11-23(20-22)28-18-16-27(17-19-28)13-3-1-2-4-14-29-24-12-5-8-21-9-7-15-30(25(21)24)33(29,31)32/h5-6,8,10-12,20H,1-4,7,9,13-19H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
GGPXOELINLEIPA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor